
    
      This is a follow-up protocol to prospectively monitor pregnancy, delivery, and neonatal
      outcome of women who were treated with corifollitropin alfa or recFSH and became pregnant
      during the base study P05690 (NCT00702845). For this trial no study specific assessments are
      required, but information as obtained in standard practice will be used.
    
  